3MNR

Crystal Structure of Benzamide SNX-1321 bound to Hsp90

3MNR の概要

• エントリーDOI: 10.2210/pdb3mnr/pdb
• 関連するPDBエントリー: 3D0B
• 分子名称: Heat shock protein HSP 90-alpha, 2-[(3,4,5-trimethoxyphenyl)amino]-4-(2,6,6-trimethyl-4-oxo-4,5,6,7-tetrahydro-1H-indol-1-yl)benzamide (3 entities in total)
• 機能のキーワード: hsp90, heat shock protein 90, protein-ligand complex, chaperone
• 由来する生物種: Homo sapiens (human)
• 細胞内の位置: Cytoplasm: P07900
• タンパク質・核酸の鎖数: 1
• 化学式量合計: 26634.93

構造登録者

Veal, J.M.,Fadden, P.,Huang, K.H.,Rice, J.,Hall, S.E.,Haytstead, T.A. (登録日: 2010-04-22, 公開日: 2010-08-11, 最終更新日: 2023-09-06)

主引用文献

Fadden, P.,Huang, K.H.,Veal, J.M.,Steed, P.M.,Barabasz, A.F.,Foley, B.,Hu, M.,Partridge, J.M.,Rice, J.,Scott, A.,Dubois, L.G.,Freed, T.A.,Silinski, M.A.,Barta, T.E.,Hughes, P.F.,Ommen, A.,Ma, W.,Smith, E.D.,Spangenberg, A.W.,Eaves, J.,Hanson, G.J.,Hinkley, L.,Jenks, M.,Lewis, M.,Otto, J.,Pronk, G.J.,Verleysen, K.,Haystead, T.A.,Hall, S.E.
Application of Chemoproteomics to Drug Discovery: Identification of a Clinical Candidate Targeting Hsp90.
Chem.Biol., 17:686-694, 2010

PubMed Abstract: A chemoproteomics-based drug discovery strategy is presented that utilizes a highly parallel screening platform, encompassing more than 1000 targets, with a focused chemical library prior to target selection. This chemoproteomics-based process enables a data-driven selection of both the biological target and chemical hit after the screen is complete. The methodology has been exemplified for the purine binding proteome (proteins utilizing ATP, NAD, FAD). Screening of an 8000 member library yielded over 1500 unique protein-ligand interactions, which included novel hits for the oncology target Hsp90. The approach, which also provides broad target selectivity information, was used to drive the identification of a potent and orally active Hsp90 inhibitor, SNX-5422, which is currently in phase 1 clinical studies.

PubMed: 20659681
DOI: 10.1016/j.chembiol.2010.04.015

実験手法

X-RAY DIFFRACTION (1.9 Å)